MyFinsight
Home
Blog
About
Silence Therapeutics plc (SLN)
Silence Therapeutics plc (SLN)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
741.55%
Quick Ratio
741.55%
Cash Ratio
566.73%
Debt to Asset Ratio
63.85%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Other current assets
Goodwill
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Contract liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
72,054
5,657
11,277
82,031
Short-term investments
0
64,421
73,837
20,161
R&d benefit receivable
9,292
22,216
22,007
22,152
Other current assets
12,935
10,558
11,537
9,260
Trade receivables
-
0
0
28
Total current assets
94,281
102,852
118,658
133,632
Property, plant and equipment
1,325
1,396
1,581
1,655
Operating lease right-of-use asset
117
142
167
192
Goodwill
10,325
10,358
10,621
10,612
Intangible assets
-
-
288
-
Other intangible assets
237
248
-
300
Other long-term assets
127
127
127
399
Total assets
106,412
115,123
131,442
146,790
Contract liabilities
0
0
168
301
Trade and other payables
12,611
10,367
13,356
16,993
Operating lease liabilities, current
103
93
89
85
Total current liabilities
12,714
10,460
13,613
17,379
Contract liabilities
55,218
55,218
55,454
55,251
Operating lease liabilities
9
43
71
97
Total liabilities
67,941
65,721
69,138
72,727
Ordinary shares - par value gbp 0.05 per share 141,739,180 shares issued at june 30, 2026 (december 31, 2025 141,701,848)
10,292
10,290
10,290
10,290
Additional paid-in capital
621,152
620,006
617,562
617,648
Accumulated deficit
-589,632
-577,526
-562,572
-550,802
Accumulated other comprehensive loss
-3,341
-3,368
-2,976
-3,073
Total shareholders' equity
38,471
49,402
62,304
74,063
Total liabilities and shareholders' equity
106,412
115,123
131,442
146,790
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$72,054K
(72.63%↑ Y/Y)
Other current assets
$12,935K
(-9.90%↓ Y/Y)
R&d benefit
receivable
$9,292K
(-53.44%↓ Y/Y)
Total current assets
$94,281K
(-36.53%↓ Y/Y)
Goodwill
$10,325K
(-2.75%↓ Y/Y)
Property, plant and
equipment
$1,325K
(-25.35%↓ Y/Y)
Other intangible
assets
$237K
(-25.24%↓ Y/Y)
Other long-term
assets
$127K
(-96.75%↓ Y/Y)
Operating lease
right-of-use asset
$117K
(101.72%↑ Y/Y)
Total assets
$106,412K
(-35.60%↓ Y/Y)
Total liabilities and
shareholders' equity
$106,412K
(-35.60%↓ Y/Y)
Total liabilities
$67,941K
(-4.41%↓ Y/Y)
Total shareholders'
equity
$38,471K
(-59.14%↓ Y/Y)
Accumulated deficit
-$589,632K
(-11.28%↓ Y/Y)
Accumulated other
comprehensive loss
-$3,341K
(-137.96%↓ Y/Y)
Contract liabilities
$55,218K
(-1.94%↓ Y/Y)
Total current
liabilities
$12,714K
(-13.91%↓ Y/Y)
Operating lease
liabilities
$9K
Additional paid-in capital
$621,152K
(0.98%↑ Y/Y)
Ordinary shares - par
value gbp 0.05 per...
$10,292K
(0.02%↑ Y/Y)
Trade and other
payables
$12,611K
(-11.88%↓ Y/Y)
Operating lease
liabilities, current
$103K
Buy us a coffee